Skip to Content

PA 2120 (Valproic Acid 250 mg)

Pill with imprint PA 2120 is White, Capsule-shape and has been identified as Valproic Acid 250 mg. It is supplied by Teva Pharmaceuticals USA.

Valproic acid is used in the treatment of epilepsy; schizoaffective disorder; seizure prevention; mania; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PA 2120

Valproic acid 250 mg PA 2120
Valproic acid 250 mg PA 2120
Valproic acid 250 mg PA 2120
Valproic acid 250 mg PA 2120

Valproic Acid

Imprint
PA 2120
Strength
250 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
50111-0852
Inactive Ingredients
corn oil, FD&C Blue No. 1, gelatin, glycerin, water, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.